# Commission Implementing Regulation (EU) No 1359/2014 of 18 December 2014 amending the Annex to Regulation (EU) No 37/2010, as regards the substance tulathromycin (Text with EEA relevance), Annex

Extent: E+W+S+N.I.

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance tulathromycin is replaced by the following:
Pharmacologically active Substance
Marker residue
Animal Species
MRL
Target Tissues
Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)
Therapeutic classification
‘Tulathromycin
(2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2-ethyl-3,4,10,13-tetra-hydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethy-lamino)-ß-D-xylo-hexopyranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalents
Bovine
300 μg/kg
200 μg/kg
4 500 μg/kg
3 000 μg/kg
Muscle
Fat
Liver
Kidney
Not for use in animals from which milk is produced for human consumption
Provisional MRLs expire on 1 January 2015
Anti-infectious agents/Antibiotics’
Porcine
800 μg/kg
300 μg/kg
4 000 μg/kg
8 000 μg/kg
Muscle
Skin and fat in natural proportions
Liver
Kidney
Provisional MRLs expire on 1 January 2015

---
Source: https://www.legislation.gov.uk/eur/2014/1359/annex (the official version)
Page: https://openlegislation.uk/eu-regulation-2014-1359/annex
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.